COVID-19 pandemic: from respect for science to investments in National Health Services

  • Wilson Jorge Correia Pinto de Abreu Escola Superior de Enfermagem do Porto, Centro de Investigação em Tecnologias e Serviços de Saúde - Universidade do Porto https://orcid.org/0000-0002-0847-824X

Abstract

January 2020. The world has woken up to a worrying reality. The city of Wuhan, capital of the province of Hubei, China, was struggling with a new virus with enormous transmission capacity. COVID-19 is a severe respiratory disease caused by the Severe Acute Respiratory Syndrome virus (SARS-CoV-2), first identified in December 2019 in Wuhan

References

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 2(15):497-506. doi: http://dx.doi.org/10.1016/S0140-6736(20)30183-5

National Health Commission. Beijing: National Health Commission of PRC (NHC). New coronavirus pneumonia diagnosis and treatment plan (trial version 6) [Internet]. 2020 [cited May 20, 2020]. Available from: http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml

Anderson R, Heesterbeek H, Klinkenberg D, Hollingsworth T. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020; 3(21):931-4. doi: https://dx.doi.org/10.1016/S0140-6736(20)30567-5

Published
2021-01-04
Section
Editorial